<p><strong>Atricure</strong>（纳斯达克股票代码：ATRC）将于 2026 年 2 月 17 日（星期二）发布最新的季度财报。以下是投资者在公告前需要了解的信息。</p>
<p>分析师预计 Atricure 将报告每股收益（EPS）为$-0.04。</p>
<p>Atricure 的公告备受期待，投资者希望获得超出预期的消息以及对下个季度的积极指引。</p>
<p>值得新投资者注意的是，指引可能是股价波动的关键因素。</p>
<h3>历史收益表现</h3>
<p>在上个季度，该公司报告的每股收益超出预期$0.10，导致次日股价下跌 3.81%。</p>
<p>以下是 Atricure 的过去表现及其导致的价格变化：</p>
<table>
<thead>
<tr>
<th><strong>季度</strong></th>
<th align="right"><strong>2025 年第三季度</strong></th>
<th align="right"><strong>2025 年第二季度</strong></th>
<th align="right"><strong>2025 年第一季度</strong></th>
<th align="right"><strong>2024 年第四季度</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS 预估</strong></td>
<td align="right">-0.11</td>
<td align="right">-0.16</td>
<td align="right">-0.22</td>
<td align="right">-0.15</td>
</tr>
<tr>
<td><strong>EPS 实际</strong></td>
<td align="right">-0.01</td>
<td align="right">-0.02</td>
<td align="right">-0.14</td>
<td align="right">-0.08</td>
</tr>
<tr>
<td><strong>价格变化 %</strong></td>
<td align="right">-4.00</td>
<td align="right">11.00</td>
<td align="right">-14.00</td>
<td align="right">-7.00</td>
</tr>
</tbody>
</table>
<p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1771272088_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="eps graph" original-src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1771272088_0.png"/></p>
<h3>Atricure 股价分析</h3>
<p>截至 2 月 12 日，Atricure 的股票交易价格为$31.8。在过去的 52 周内，股价下跌了 14.57%。鉴于这些回报通常为负，长期股东在此次财报发布前可能感到不满。</p>
<h3>分析师对 Atricure 的看法</h3>
<p>了解市场情绪和行业内的预期对投资者至关重要。本文分析了 Atricure 的最新见解。</p>
<p>根据分析师评级，Atricure 的共识评级为。平均一年价格目标为$，表明潜在的。</p>
<p>要跟踪 Atricure 的所有财报发布，请访问我们网站上的财报日历。</p>
<p><em>本文由 Benzinga 的自动内容引擎生成，并由编辑审核。</em></p>

ATRC

<p>AtriCure（纳斯达克代码：ATRC）将于 2026 年 2 月 17 日公布季度财报，分析师预计每股收益（EPS）为-0.04 美元。投资者热切期待此次公告，以期获得潜在的积极指引。上个季度，AtriCure 的每股收益超出预期 0.10 美元，但股价随后下跌了 3.81%。目前，股价为 31.8 美元，过去一年下跌了 14.57%。分析师评级和市场情绪对投资者在财报发布前至关重要</p>

<p><strong>AtriCure</strong> (NASDAQ: ATRC) is set to give its latest quarterly earnings report on Tuesday, 2026-02-17. Here's what investors need to know before the announcement.</p>
<div class="lb-trans"><p><strong>Atricure</strong>（纳斯达克股票代码：ATRC）将于 2026 年 2 月 17 日（星期二）发布最新的季度财报。以下是投资者在公告前需要了解的信息。</p>
</div><p>Analysts estimate that AtriCure will report an <strong>earnings per share</strong> (EPS) of $-0.04.</p>
<div class="lb-trans"><p>分析师预计 Atricure 将报告每股收益（EPS）为$-0.04。</p>
</div><p>The announcement from AtriCure is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<div class="lb-trans"><p>Atricure 的公告备受期待，投资者希望获得超出预期的消息以及对下个季度的积极指引。</p>
</div><p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<div class="lb-trans"><p>值得新投资者注意的是，指引可能是股价波动的关键因素。</p>
</div><h3>Historical Earnings Performance</h3>
<div class="lb-trans"><h3>历史收益表现</h3>
</div><p>During the last quarter, the company reported an EPS beat by $0.10, leading to a 3.81% drop in the share price on the subsequent day.</p>
<div class="lb-trans"><p>在上个季度，该公司报告的每股收益超出预期$0.10，导致次日股价下跌 3.81%。</p>
</div><p>Here's a look at AtriCure's past performance and the resulting price change:</p>
<div class="lb-trans"><p>以下是 Atricure 的过去表现及其导致的价格变化：</p>
</div><table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th align="right"><strong>Q3 2025</strong></th>
<th align="right"><strong>Q2 2025</strong></th>
<th align="right"><strong>Q1 2025</strong></th>
<th align="right"><strong>Q4 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td align="right">-0.11</td>
<td align="right">-0.16</td>
<td align="right">-0.22</td>
<td align="right">-0.15</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td align="right">-0.01</td>
<td align="right">-0.02</td>
<td align="right">-0.14</td>
<td align="right">-0.08</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td align="right">-4.00</td>
<td align="right">11.00</td>
<td align="right">-14.00</td>
<td align="right">-7.00</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th><strong>季度</strong></th>
<th align="right"><strong>2025 年第三季度</strong></th>
<th align="right"><strong>2025 年第二季度</strong></th>
<th align="right"><strong>2025 年第一季度</strong></th>
<th align="right"><strong>2024 年第四季度</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS 预估</strong></td>
<td align="right">-0.11</td>
<td align="right">-0.16</td>
<td align="right">-0.22</td>
<td align="right">-0.15</td>
</tr>
<tr>
<td><strong>EPS 实际</strong></td>
<td align="right">-0.01</td>
<td align="right">-0.02</td>
<td align="right">-0.14</td>
<td align="right">-0.08</td>
</tr>
<tr>
<td><strong>价格变化 %</strong></td>
<td align="right">-4.00</td>
<td align="right">11.00</td>
<td align="right">-14.00</td>
<td align="right">-7.00</td>
</tr>
</tbody>
</table>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1771272088_0.png" alt="eps graph" original-src="https://www.benzinga.com/files/images/story/2026/1771272088_0.png"/></p>
<h3>AtriCure Share Price Analysis</h3>
<div class="lb-trans"><h3>Atricure 股价分析</h3>
</div><p>Shares of AtriCure were trading at $31.8 as of February 12. Over the last 52-week period, shares are down 14.57%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.</p>
<div class="lb-trans"><p>截至 2 月 12 日，Atricure 的股票交易价格为$31.8。在过去的 52 周内，股价下跌了 14.57%。鉴于这些回报通常为负，长期股东在此次财报发布前可能感到不满。</p>
</div><h3>Analyst Opinions on AtriCure</h3>
<div class="lb-trans"><h3>分析师对 Atricure 的看法</h3>
</div><p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on AtriCure.</p>
<div class="lb-trans"><p>了解市场情绪和行业内的预期对投资者至关重要。本文分析了 Atricure 的最新见解。</p>
</div><p>With analyst ratings, AtriCure has a consensus rating of . The average one-year price target is $, indicating a potential .</p>
<div class="lb-trans"><p>根据分析师评级，Atricure 的共识评级为。平均一年价格目标为$，表明潜在的。</p>
</div><p>To track all earnings releases for AtriCure visit their earnings calendar on our site.</p>
<div class="lb-trans"><p>要跟踪 Atricure 的所有财报发布，请访问我们网站上的财报日历。</p>
</div><p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>
<div class="lb-trans"><p><em>本文由 Benzinga 的自动内容引擎生成，并由编辑审核。</em></p>
</div>

Atricure 即将发布的财报洞察